In 2023, total pharmaceutical sales in Japan stood at 9.4588 trillion Japanese Yens.
Forecasted data for the upcoming years show projected sales as follows: 9.5804 trillion Yens in 2024, 9.7055 trillion Yens in 2025, 9.8293 trillion Yens in 2026, 9.952 trillion Yens in 2027, and 10.073 trillion Yens in 2028.
Key Year-on-Year Variations:
- 2024: An increase of 1.29% from the previous year's figures.
- 2025: A growth of 1.30% from the year 2024.
- 2026: An increase of 1.27% from the previous year.
- 2027: A rise of 1.25% from the year 2026.
- 2028: A growth of 1.22% from the year 2027.
The Compound Annual Growth Rate (CAGR) over the last five years (2023-2028) is estimated at approximately 1.27% per year.
Future trends to watch for include rising demand for innovative biologics, increasing aging population leading to higher healthcare expenditures, and potential policy changes affecting pricing and market access.
